Ophthalmology, Fertility, Dialysis, Dental, Cardiology & Specialty Chains
Single-Speciality Chains
Executive Search
65+ Specialty Chain Placements — with an average 66 Days time-to-placement and a 12-month candidate guarantee.
65+
Specialty Chain Placements
66 Days
Avg. Time-to-Placement
93%
Offer Acceptance Rate
12 Months
Candidate Guarantee
Specialisation withinHealthcare & Life Sciences·Advancing Human Health
Single-speciality chains are the fastest-growing sub-segment of Indian healthcare. Eye care, fertility, dialysis, oncology, cardiology, dental, orthopaedics, mother-and-child, and mental health have each produced category-leading chains with hundreds of clinics, PE-backed scale ambitions, and — increasingly — IPO runway. The operating model differs meaningfully from multi-speciality hospitals: protocol-driven clinical workflows, higher asset turns, faster new-centre ramp-up, tighter clinician-engagement economics, and specific payor-mix dynamics (OPD-heavy, walk-in-driven, selective insurance participation). Leadership hiring reflects that distinctiveness — the candidate pool is narrower than multi-speciality, specialist clinical fluency matters more, and the ability to institutionalise protocol-based care while scaling is the defining operating skill.
Is This Your Situation?
If any of these sound familiar, you're speaking to the right practice.
→PE-backed eye-care chain targeting an IPO window hiring a CFO with DRHP-drafting experience, alongside a Head of Clinical Quality to institutionalise enterprise-wide protocol governance.
→Fertility chain consolidating three acquisitions hiring a COO with multi-centre integration experience and parallel Head of Clinician Engagement to protect anchor-specialist retention.
→Listed oncology chain running CMO succession — confidential search with specialty-pedigree requirement and board Nomination Committee participation.
→Mental-health platform (asset-light, clinician-supply-constrained) hiring a CEO with specialty-chain scale experience and parallel Head of Clinician Supply.
Our Single-Speciality Chains Track Record
Situation:
A category-leading PE-backed eye care chain with 200+ centres needed a CEO succession ahead of an IPO window. The brief required specialty-chain operating rhythm, IPO-readiness narrative for the sponsor, and credibility with the anchor ophthalmologist community whose retention materially drove clinic-level volumes.
Outcome:
Placed a CEO with prior specialty-chain leadership at a comparable category-leader and subsequent consumer-healthcare GM experience. Engagement included confidential pre-reads with three anchor ophthalmologist advisors and alignment with the PE sponsor's investment committee. Transition was completed alongside the DRHP drafting milestone.
Situation:
A consolidating fertility chain with 50+ centres across India needed a CMO with reproductive-endocrinology specialty pedigree, enterprise-scale clinical governance experience, and the gravitas to chair the internal Medical Advisory Board that governed protocol standardisation across the chain's acquired centres.
Outcome:
Placed a CMO with fellowship-level reproductive-endocrinology credentials and prior enterprise-scale clinical governance leadership at a multi-speciality flagship. Engagement included a parallel Head of Clinical Protocols placement to anchor the protocol-standardisation programme.
Situation:
A pre-IPO dialysis platform operating 120+ centres needed a CFO with DRHP-drafting experience, SEBI LODR fluency, and familiarity with specialty-chain-specific revenue recognition (per-session billing, insurance package pricing, government-scheme reimbursement cycles) — run in active parallel with merchant-banker DRHP timelines.
Outcome:
Placed a CFO with prior listed-healthcare CFO experience and subsequent PE-held platform CFO tenure. Engagement included a parallel Head of Investor Relations placement. The CFO led DRHP drafting through merchant-banker review and audit-committee sign-off within the sponsor's target window.
All client details anonymised. Specific mandates available for reference under NDA upon request.
Our Single-Speciality Chains Practice
Single-speciality chains are the fastest-growing sub-segment of Indian healthcare. Eye care, fertility, dialysis, oncology, cardiology, dental, orthopaedics, mother-and-child, and mental health have each produced category-leading chains with hundreds of clinics, PE-backed scale ambitions, and — increasingly — IPO runway. The operating model differs meaningfully from multi-speciality hospitals: protocol-driven clinical workflows, higher asset turns, faster new-centre ramp-up, tighter clinician-engagement economics, and specific payor-mix dynamics (OPD-heavy, walk-in-driven, selective insurance participation). Leadership hiring reflects that distinctiveness — the candidate pool is narrower than multi-speciality, specialist clinical fluency matters more, and the ability to institutionalise protocol-based care while scaling is the defining operating skill.
We place leaders across eye-care chains, fertility and IVF chains, dialysis platforms, oncology networks, cardiology chains, dental service organisations (DSOs), orthopaedic centres, mother-and-child specialty groups, mental-health platforms, and emerging niche specialty chains (pain management, sleep medicine, lifestyle diseases). Engagements include CEO and MD appointments, Chief Medical Officers with deep specialty pedigree, COOs with multi-centre scale discipline, CFOs for IPO-ready chains, and board chairs and independent directors for listed and pre-IPO specialty groups.
Our practice is calibrated to the observation that specialty chains are a category of their own and candidates rarely transfer well from multi-speciality hospitals or from non-healthcare consumer services. The operating rhythm (asset-light clinics, walk-in OPD volume, specialty-equipment utilisation, clinician supply constraints) and the commercial rhythm (cash-pay heavy, insurance selectively empanelled, package-pricing disciplined) create a distinctive leadership profile we look for.
As a specialist CEO mandates in healthcare, our practice also covers COO leadership for multi-centre chains, our practice also covers Pre-IPO CFO searches, and as a source for Healthcare & Life Sciences practice overview.
The Single-Speciality Chains Landscape Today
Single-speciality healthcare in India is estimated at $30 billion+ and compounding at 20%+ annually — faster than multi-speciality hospitals — driven by consumer-health aspiration, insurance selective penetration, disposable income growth, and the structural preference for specialty-focused care in high-value clinical conditions. Eye care is the largest single-speciality segment, with multiple chains crossing 200+ centres and listing-ready scale. Fertility and IVF has seen rapid consolidation and PE backing, with category-leading chains running 40-100+ centres under standardised protocols. Dialysis has become a platform business, with PE-backed chains running network-dialysis operations that combine clinical protocol discipline with high-volume recurring-revenue economics. Oncology has fragmented into medical-oncology day-care chains, surgical-oncology specialty hospitals, and radiation-oncology networks. Cardiology, dental, orthopaedic, mental-health, and mother-and-child chains are all in active PE-backed consolidation. Leadership compensation has re-rated alongside PE capital entering the category — CEOs of category-leading single-speciality chains now command packages comparable to mid-size multi-speciality hospital-group CEOs. The IPO window has opened for several single-speciality chains, adding a board-level governance and investor-relations layer that was previously absent from the sub-sector.
Key Leadership Challenges in Single-Speciality Chains
CEO / MD hiring for category-leading single-speciality chains — leaders who can compound clinic network growth while maintaining protocol-discipline clinical quality.
Chief Medical Officer hiring — specialist physician-leaders with deep specialty pedigree (FRCS / DNB / fellowship-trained in the relevant specialty) and administrative leadership capacity.
COO and Head of Operations for multi-centre chains — operators who understand clinic-unit economics, chair-utilisation (for dental, fertility), chair-time economics (for dialysis, oncology), and clinician-supply dynamics.
CFO hiring for IPO-ready specialty chains — including DRHP-drafting experience, SEBI LODR fluency, and single-speciality-specific disclosures.
Clinical Heads, Medical Directors, and Department Chairs — specialty-pedigree clinicians with enterprise-scale clinical governance experience.
Board chairs and independent directors for listed and pre-IPO specialty groups, particularly those with both specialty gravitas and consumer-business pedigree.
What We Look For in Single-Speciality Chains Leaders
Across mandates, single-speciality chains leadership tends to cluster into a small set of archetypes. We calibrate each search against the profile your board actually needs — not the one most commonly available.
The Specialty-Chain CEO
Executive who has run a single-speciality chain P&L through scale — fluent in multi-centre clinic economics, clinician-supply dynamics, payor selectivity, and the consumer-brand positioning specific to specialty healthcare.
The Specialty CMO
Physician-leader with deep specialty pedigree (relevant fellowship / academic training) and administrative leadership experience. Owns clinical governance, specialty-protocol standardisation, and specialist-clinician engagement frameworks.
The Multi-Centre COO
Operations leader who has run a 50-200 centre clinic network — fluent in clinic-unit economics, equipment utilisation, clinician-roster planning, payor empanelment, and new-centre commissioning rhythm.
The IPO-Ready Specialty CFO
Finance leader with DRHP-drafting and SEBI LODR experience, specifically in single-speciality revenue recognition, procedure-level cohort economics, and specialty-chain-specific investor-relations storytelling.
The Clinical Quality Head
Enterprise-scale clinical governance leader who has built protocol libraries, peer-review frameworks, adverse-event reporting cultures, and accreditation readiness across multi-centre networks.
The Clinician Supply Leader
Specialty-healthcare HR / talent leader who has built institutional clinician-recruitment, residency-adjacent pipelines, and retention-architecture practices tuned to the specific specialty's labour-market constraints.
Regulatory & Compensation Context
Regulatory Backdrop
Single-speciality chains operate under many of the same regulatory frameworks as multi-speciality hospitals — Clinical Establishments Act, NABH accreditation, state medical council physician credentialing — plus several specialty-specific overlays. The PCPNDT Act is a first-order compliance concern for any chain with diagnostic-imaging specialties involving foetal imaging. The Surrogacy (Regulation) Act and Assisted Reproductive Technology (Regulation) Act are standing obligations for fertility chains. The Transplantation of Human Organs Act affects dialysis chains with transplant-adjacent programmes. Oncology chains operate under AERB regulations for radiation oncology and specific SOP obligations around chemotherapy protocols. Mental health chains operate under the Mental Healthcare Act, which has specific consent, admission, and treatment-documentation requirements. Dental chains operate under the Dentists Act and state-council overlays. Insurance empanelment — particularly for specialty-procedure care — involves specialty-specific package pricing and utilisation-review regimes. For listed and pre-IPO specialty chains, SEBI LODR disclosures around procedure volumes, average revenue per patient, and clinic utilisation have become specialty-chain-specific investor-relations topics. DPDP Act applicability to specialty-specific sensitive data (fertility, mental health, oncology patient data) requires specialty-tuned privacy architecture.
Compensation Architecture
Single-speciality chain CEO compensation has re-rated significantly as PE capital has entered the category. A CEO of a category-leading pre-IPO specialty chain commands ₹4-8 crore fixed cash, 50-100% annual bonus, and equity participation at 1-3% (hired CEO) with meaningful secondary liquidity opportunities. Listed specialty-chain CEOs compound these ranges further. CMOs with specialty pedigree command ₹2.5-5 crore fixed — higher for specialties with particularly constrained senior-clinician supply (medical oncology, reproductive endocrinology, paediatric cardiology). COOs with multi-centre chain experience price at ₹2-4.5 crore fixed. IPO-ready specialty CFOs sit at ₹2.5-5 crore fixed with 0.5-1.5% equity. Heads of Clinical Quality command ₹1.5-3 crore. Regional / Cluster heads at 20-40 centre scale price at ₹1.5-3 crore fixed. Clinician-supply leadership is typically priced at ₹1.2-2.5 crore fixed — a meaningful premium over generic CHRO comp given the specialty-specific HR sophistication. Independent directors on listed specialty-chain boards are compensated at ₹35-65 lakh per year in cash plus committee-chair premiums. Retention for senior anchor-specialists (the clinicians who drive clinic-level patient volume) is a separate conversation that intersects with leadership hiring — we advise clients on clinical-equity, academic-affiliation, and confidential-scope levers.
Roles We Typically Place
Why Gladwin International Leadership Advisors for Single-Speciality Chains
CEO / MD searches for single-speciality chains across eye care, fertility, dialysis, oncology, cardiology, dental, orthopaedics, mother-and-child, and mental-health.
Chief Medical Officer / Medical Director searches — specialty-pedigree physician leaders with commercial and governance fluency.
COO and multi-centre operations leader placements.
CFO searches for pre-IPO and listed single-speciality chains.
Clinical Heads, Department Chairs, and senior specialty-clinician leaders (including those who take up MD / CEO pathways).
Independent directors, board chairs, and audit committee chairs with specialty-healthcare fluency.
Organisations We Serve
Listed and pre-IPO single-speciality chains
PE-backed specialty healthcare platforms
Category-leading eye care, fertility, dialysis, and oncology chains
Dental service organisations (DSOs)
Mother-and-child, mental-health, and emerging niche specialty chains
Specialty medical-device companies with captive clinic networks
Single-Speciality Chains leaders assessed on the Healthcare “VITALIS” framework
Seven dimensions calibrated for healthcare and life sciences leadership. Dimensions are calibrated for single-speciality chains mandates where relevant.
Parent Practice
Return to Healthcare & Life Sciences
Discuss a Single-Speciality Chains Mandate
Confidential · No obligation
Response within 4 business hours · All enquiries handled by a senior practice partner · Strictly confidential